• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus.

作者信息

Xu Jianyong, Lian Wei, Wu Huimei, Wang Xianqi, Chen Jiayu, Yang Lei, Zhuang Xinyu, Li Lingyun, Huang Zhong

机构信息

Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Immunology, Health Science Center, Shenzhen University, Shenzhen, 518055, P. R. China.

出版信息

Cell Mol Immunol. 2020 Oct;17(10):1104-1106. doi: 10.1038/s41423-020-0364-4. Epub 2020 Feb 5.

DOI:10.1038/s41423-020-0364-4
PMID:32024977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7608228/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/667e/7641116/cdc9a16066c5/41423_2020_364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/667e/7641116/cdc9a16066c5/41423_2020_364_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/667e/7641116/cdc9a16066c5/41423_2020_364_Fig1_HTML.jpg

相似文献

1
Improved therapeutic consistency and efficacy of mesenchymal stem cells expanded with chemically defined medium for systemic lupus erythematosus.用化学成分明确的培养基扩增的间充质干细胞治疗系统性红斑狼疮的治疗一致性和疗效得到改善。
Cell Mol Immunol. 2020 Oct;17(10):1104-1106. doi: 10.1038/s41423-020-0364-4. Epub 2020 Feb 5.
2
Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.间充质干细胞治疗系统性红斑狼疮的应用。
Adv Exp Med Biol. 2018;1089:73-85. doi: 10.1007/5584_2018_212.
3
Serum IFN-γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients.血清 IFN-γ 可预测间充质干细胞移植治疗系统性红斑狼疮患者的疗效。
Stem Cells Transl Med. 2017 Sep;6(9):1777-1785. doi: 10.1002/sctm.17-0002. Epub 2017 Jul 29.
4
Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.同种异体骨髓间充质干细胞移植治疗系统性红斑狼疮。
Expert Opin Biol Ther. 2010 May;10(5):701-9. doi: 10.1517/14712591003769816.
5
Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus.同种异体间充质干细胞对系统性红斑狼疮的免疫治疗作用。
Lupus. 2020 Jul;29(8):872-883. doi: 10.1177/0961203320928419.
6
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.人脐带间充质干细胞治疗通过 miR-199a-5p/Sirt1/p53 轴增加 CD4+T 细胞衰老改善狼疮。
Theranostics. 2021 Jan 1;11(2):893-905. doi: 10.7150/thno.48080. eCollection 2021.
7
Mesenchymal stem cells induced CD4+ T cell apoptosis in treatment of lupus mice.间充质干细胞诱导 CD4+T 细胞凋亡治疗狼疮小鼠。
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):30-35. doi: 10.1016/j.bbrc.2018.10.133. Epub 2018 Nov 5.
8
Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?类风湿关节炎和系统性红斑狼疮中的多能间充质基质细胞；从发病机制中的主要角色到潜在的治疗救星？
Front Immunol. 2021 Feb 24;12:643170. doi: 10.3389/fimmu.2021.643170. eCollection 2021.
9
CXCR3-deficient mesenchymal stem cells fail to infiltrate into the nephritic kidney and do not ameliorate lupus symptoms in MRL. Fas mice.缺乏CXCR3的间充质干细胞无法浸润到患肾炎的肾脏中，也不能改善MRL.Fas小鼠的狼疮症状。
Lupus. 2018 Oct;27(11):1854-1859. doi: 10.1177/0961203318794871. Epub 2018 Aug 23.
10
Toll-like receptor signalling associated with immunomodulation of umbilical cord-derived mesenchymal stem cells in mice with systemic lupus erythematosus.Toll 样受体信号通路与系统性红斑狼疮小鼠脐带间充质干细胞免疫调节的关系。
Lupus. 2020 Feb;29(2):165-175. doi: 10.1177/0961203319898532. Epub 2020 Jan 21.

引用本文的文献

1
CD317 stabilizes TNFR1 and confers the anti-inflammatory functions of MSCs via NF-κB/TSG6 pathway.CD317使TNFR1稳定，并通过NF-κB/TSG6途径赋予间充质干细胞抗炎功能。
Stem Cell Res Ther. 2025 Jul 21;16(1):391. doi: 10.1186/s13287-025-04527-8.
2
Application of mesenchymal stem cells in liver fibrosis and regeneration.间充质干细胞在肝纤维化和肝再生中的应用。
Liver Res. 2024 Nov 26;8(4):246-258. doi: 10.1016/j.livres.2024.11.004. eCollection 2024 Dec.
3
Enhanced myofibroblast differentiation of eMSCs in intrauterine adhesions.
子宫粘连中子宫内膜间充质干细胞的肌成纤维细胞分化增强。
Stem Cell Res Ther. 2025 Feb 4;16(1):35. doi: 10.1186/s13287-025-04183-y.
4
Hydrogel-based approaches to target hypersensitivity mechanisms underlying autoimmune disease.基于水凝胶的方法靶向自身免疫性疾病潜在的过敏机制。
Adv Drug Deliv Rev. 2024 Sep;212:115395. doi: 10.1016/j.addr.2024.115395. Epub 2024 Jul 14.
5
Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.揭示间充质干细胞的异质性：探索基于标志物的策略来定义 MSC 亚群。
J Transl Med. 2024 May 15;22(1):459. doi: 10.1186/s12967-024-05294-5.
6
Improved therapeutic consistency and efficacy of CD317 MSCs through stabilizing TSG6 by PTX3.通过 PTX3 稳定 TSG6 可提高 CD317MSCs 的治疗一致性和疗效。
Stem Cell Res Ther. 2024 Mar 27;15(1):92. doi: 10.1186/s13287-024-03706-3.
7
CD317 MSCs expanded with chemically defined media have enhanced immunological anti-inflammatory activities.用化学定义的培养基扩增的 CD317MSCs 具有增强的免疫抗炎活性。
Stem Cell Res Ther. 2024 Jan 2;15(1):2. doi: 10.1186/s13287-023-03618-8.
8
Effect of Expansion Media on Functional Characteristics of Bone Marrow-Derived Mesenchymal Stromal Cells.扩张介质对骨髓间充质干细胞功能特性的影响。
Cells. 2023 Aug 19;12(16):2105. doi: 10.3390/cells12162105.
9
TNFAIP6 defines the MSC subpopulation with enhanced immune suppression activities.TNFAIP6 定义了具有增强免疫抑制活性的 MSC 亚群。
Stem Cell Res Ther. 2022 Sep 24;13(1):479. doi: 10.1186/s13287-022-03176-5.
10
Comparative analysis of mesenchymal stem cells cultivated in serum free media.无血清培养基中培养的间充质干细胞的比较分析。
Sci Rep. 2022 May 21;12(1):8620. doi: 10.1038/s41598-022-12467-z.